Search

everythinglearnresearchcommunity

for

Search:↓

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Cyclosporin doesn't stop hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

A mouse model was created to study hair loss similar to humans.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.